Global Next Generation Sequence Market Size To Exceed USD 33.8 Billion by 2035| CAGR of 11.31%
Category: HealthcareAccording to a research report published by Spherical Insights & Consulting, The Global Next Generation Sequence Market Size is Expected To Grow from USD 10.4 Billion in 2024 to USD 33.8 Billion by 2035, at a CAGR of 11.31% during the Forecast Period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 240 pages with 120 Market data tables and figures & charts from the report on the "Global Next Generation Sequence Market Size, Share, and COVID-19 Impact Analysis, By Technology (WGS, Whole Exome Sequencing, Targeted Sequencing & Resequencing, and Others), By Product (Platform and Consumables), By Application (Oncology, Clinical Investigation, Reproductive Health, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics, and Consumer Genomics), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/next-generation-sequence-market
The next generation sequencing (NGS) market refers to the industry centered on advanced DNA sequencing technologies that enable rapid, high-throughput, and cost-effective analysis of genetic material. Unlike traditional sequencing methods, NGS offers comprehensive insights into genomes, transcriptomes, and epigones, making it essential in research and clinical applications. Driving factors include the rising prevalence of cancer and genetic disorders, growing adoption of precision medicine, technological advancements such as single-cell and long-read sequencing, and declining sequencing costs that expand accessibility. Government initiatives and increasing investment in genomics also support growth. However, restraining factors include high equipment costs, complex data interpretation requiring advanced bioinformatics, regulatory hurdles, reimbursement challenges, and limited skilled professionals, which can hinder widespread clinical adoption, especially in developing regions.
The targeted sequencing & resequencing segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the technology, the next generation sequence market is divided into WGS, whole exome sequencing, targeted sequencing & resequencing, and others. Among these, the targeted sequencing & resequencing segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. This is attributed to targeted sequencing & resequencing dominated the 2024 NGS market due to its cost-effectiveness, faster turnaround, and higher accuracy for specific genes. Its broad clinical utility in oncology, genetic disease testing, and biomarker discovery further drives adoption, ensuring strong future growth
The consumables segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the product, the next generation sequence market is divided into platform and consumables. Among these, the consumables segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. This is attributed to the recurrent usage and high demand for consumables in both commercial and research applications of NGS. These consumables include sample preparation kits and target enrichment kits, which are essential for the sequencing process.
The oncology segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the application, the next generation sequence market is divided into oncology, clinical investigation, reproductive health, HLA typing/immune system monitoring, metagenomics, epidemiology & drug development, agrigenomics & forensics, and consumer genomics. Among these, the oncology segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. This is attributed to the increasing prevalence of cancer and the growing adoption of NGS technologies in cancer research and diagnostics.
North America is expected to hold the majority share of the global next generation sequence market over the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global next generation sequence market during the forecast period. North America’s dominance in the next generation sequencing market is driven by advanced healthcare infrastructure, high R&D investment, widespread adoption of NGS technologies, strong presence of key market players, and increasing prevalence of genetic disorders and cancer research initiatives.
Asia Pacific is anticipated to grow at the fastest pace in the global next generation sequence market during the forecast period. Asia Pacific’s NGS market is projected to grow fastest due to rising healthcare expenditure, increasing prevalence of genetic disorders and cancer, expanding research infrastructure, growing awareness of personalized medicine, and supportive government initiatives promoting genomics and biotechnology advancements.
Major vendors in the global next generation sequence market are Illumina, F. Hoffman-La Roche Ltd., QIAGEN, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies, PierianDx, Genomatix GmbH, DNASTAR, Inc., Perkin Elmer, Inc., Eurofins GATC Biotech GmbH, and BGI.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- December 2023, Oxford Nanopore introduced TurBOT beta access in collaboration with Tecan. Customers are expected to receive the products in Q1 2024. TurBOT is a benchtop instrument enabling efficient basecalling, data analysis, automated extraction, and library preparation for multiple samples in a single unit.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the next generation sequence market based on the below-mentioned segments:
Global Next Generation Sequence Market, By Technology
- WGS
- Whole Exome Sequencing
- Targeted Sequencing & Resequencing
- Others
Global Next Generation Sequence Market, By Product
- Platform
- Consumables
Global Next Generation Sequence Market, By Application
- Oncology
- Clinical Investigation
- Reproductive Health
- HLA Typing/Immune System Monitoring
- Metagenomics
- Epidemiology & Drug Development
- Agrigenomics & Forensics
- Consumer Genomics
Global Next Generation Sequence Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?